Policy Briefings

Alcami Expands Durham Laboratory by 20,000 sq. ft to Boost Biologics and CGT Capabilities

Stevanato Group Expands Drug Delivery Device Manufacturing in Germany

Upperton Expands GMP Capabilities with 3P Innovation Fill2Weight System

SunRock Biopharma Partners with Chime Biologics to Develop SRB5 for IBD

Charles River Laboratories Partners with X-Chem to Expand Hit Identification Capabilities

Codis Secures Growth Investment from 1315 Capital to Expand Haverhill Facility

MilliporeSigma Launches AAV Express Platform to Streamline Gene Therapy Manufacturing

Samsung Biologics Approves Spin-Off to Separate CDMO and Biosimilar Businesses

Polypeptide Group Expands Ambernath Facility, Tripling Production Capacity

Phlow Corp. Selected for FDA National Priority Voucher Pilot Program for ketamine API

Peptinovo Biopharma Partners with Ardena for Clinical Trial Manufacturing of Cancer Nanotherapy

Syngene International Launches State-of-the-Art Bengaluru Peptide Lab for Scalable Synthesis

Recipharm Supports Phase 2 Clinical Trials of Novel Pneumococcal Vaccine PnuBioVax®

Almac Group Invests $48 Million in eClinical Technologies and Launches Almac Trial Coordinator™

Quintara Biosciences Completes Acquisition of Laragen Sanger Sequencing

Sterling Pharma Solutions Appoints Karl Rotthier as CEO

Aragen Appoints Neeraj Garg as CEO of Discovery Solutions Business

MilliporeSigma to Acquire JSR Life Sciences’ Chromatography Business by 2026